14 - 79 - ROSACEA Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

In general, what are the possible signs and symptoms of rosacea

A
  • flushing
  • transient erythema
  • persistent erythema
  • telangiectasia
  • papules
  • pustules
  • phymata
  • edema
  • pain
  • stinging or burning
  • pruritus (very rarely)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hallmark of rosacea

A

flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in younger female and male patients, what are often the first symptoms

A

flushing and erythema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Persistent erythema (from Greek erythros, red) is defined as erythema that lasts for at least how many months

A

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

in older adults, what are often the first symptom

A

telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It constitutes an abnormal redness of the skin or mucous membranes caused by vasodilation of arterioles or capillaries, resulting in increased perfusion and thus redness.

A

Erythema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phymatous rosacea is a persistent, firm, nonpainful, nonpitting swelling of the tissue of the NOSE

A

rhinophyma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phymatous rosacea is a persistent, firm, nonpainful, nonpitting swelling of the tissue of the CHIN

A

GNATHOPHYMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phymatous rosacea is a persistent, firm, nonpainful, nonpitting swelling of the tissue of the FOREHEAD

A

METOPHYMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phymatous rosacea is a persistent, firm, nonpainful, nonpitting swelling of the tissue of the EYELIDS

A

BLEPHAROPHYMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

involves reactive vascular changes in the face that can be observed in normal individuals for a few seconds or few minutes

A

flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Physiologically, it can occur in response to various stimuli, especially heat, certain foods, alcohol, exercising, or stressful emotional stimuli.

A

flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Flushing in rosacea is a pathophysiological neurovascular process in the central face experienced for more than how many minutes?

A

5 - 10 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Flushing in rosacea is a pathophysiological neurovascular process in the central face experienced for more than 5 to 10 minutes because of ___________

A

neuropeptide release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

most common complaint in patients with rosacea

A

Prolonged and frequent flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Transient erythema is a prolonged unphysiological flushing that persists for more than _______ mins and possibly as long as weeks or a few months but for no more than 3 months.

A

5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F. Blushing is not a feature of rosacea

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

almost exclusively induced by emotionally stressful situations and not by spicy food or other rosacea trigger factors

A

Blushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It is characterized by sudden transient (mostly <5 minutes), pinkish involuntary redness of the peripheral cheeks, ears, retroauricular areas, neck, and chest, which can occur over years and often starts in early adulthood

A

Blushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

“Pale islands” in between the salmon-like redness are also characteristic of

A

blushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

distinct subform of rosacea defined by chronic, therapy-resistant, 0.2- to 0.3-cm-sized, often follicular brown-red or red papules that can develop to epithelioid (lupoid), granulomatous plaques and nodules on the cheek, forehead, or chin.

The skin appears thickened and erythematous.

Typically, the centrofacial and perioral regions of the face are affected.

A

LUPOID OR GRANULOMATOUS ROSACEA

21
Q

rare, acute or subacute, developing, maximal variant of rosacea with acne conglobatelike progression and predilection for postadolescent (20–30 years) women, particularly pregnant women

A

ROSACEA FULMINANS PYODERMA FACIALEO’LEARY

22
Q

Common Rosacea Triggers

A
23
Q

subtype of rosacea characterized as persistent central facial erythema, frequent flushing; may be telangiectatic vessels

A

erythematotelangiectatic

24
Q

subtype of rosacea characterized as erythematous dome-shaped papules, some with surmounting postulation in a centrofacial distribution on a background of persistent erythema

A

papulopustular

25
Q

subtype of rosacea characterized as Persistent facial swelling with hypertrophy of tissue (rhinophyma);

A

phymatous

26
Q

subtype of rosacea characterized as Ocular inflammation (eg, blepharitis, conjunctivitis, or meibomian gland dysfunction; chalazion)

A

Ocular rosacea

27
Q

T/F. The bilateral facial location of a presentation is considered typical but not essential.

A

True

28
Q

T/F. Flushing, telangiectasia, and inflammatory papules or pustules are considered major features and are diagnostic of rosacea.

A

False

considered major features but are not diagnostic of rosacea.

29
Q

What are the diagnostic features of rosacea

A
30
Q

What are the Major features of rosacea

A
31
Q

What are the secondary features of rosacea

A
32
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Inflammatory papules and pustules
A

MAJOR FEATURE

33
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Edema
A

secondary feature

34
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • dry sensation of skin
A

secondary feature

35
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Persistent centrofacial erythema associated with periodic intensification by potential trigger factors
A

DIAGNOSTIC FEATURE

36
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • TELANGIECTASIA
A

MAJOR FEATURE

37
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Phymatous changes
A

DIAGNOSTIC FEATURE

38
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Flushing or transient erythema
A

MAJOR FEATURE

39
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Stinging sensation of the skin
A

SECONDARY FEATURE

40
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Burning sensation of the skin
A

SECONDARY FEATURE

41
Q

Identify if this is Diagnostic, Major or Secondary Feature of rosacea

  • Ocular manifestation
A

MAJOR FEATURE

42
Q

Classification of rhinophymata: Distal end, apex of nose

A

Group 1

43
Q

Classification of rhinophymata: Complete nose, including bridge and nasofacial sulci

A

Group 4

44
Q

Classification of rhinophymata: Distal half of nose, apex, alar nodules

A

Group 3

45
Q

Classification of rhinophymata: Distal half nose, apex, alae,

A

Group 2

46
Q

Classification of Ocular rosacea: pain, photosensitivity, blurred vision, loss of eyelashes, severe conjunctival inflammation, corneal changes, scleritis or episcleritis, uveitis, iritis

A

Severe

47
Q

Classification of Ocular rosacea: burning of eyes; crusting or irregularity of eyelid margins with erythema and edema; formation of chalazion or hordeolum)

A

Moderate

48
Q

Classification of Ocular rosacea: mild itch, dryness or grittiness of the eyes; fine scaling of eyelid margins; telangiectasia and erythema of eyelid margins; mild conjunctival injection.

A

Mild

49
Q

For persistent erythema, approved therapeutic regimens

A

Topical brimonidine gel (1%) and oxymetazoline crème (1%)

Beta-blockers such as carvedilol can be used off label and should be tapered down